IperionX Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Selling, General & Admin	25.5	13.07	8	6.65	6.26	1.56
Research & Development	16.54	12.57	8.66	5.6	1.08	-
Other Operating Expenses	1.18	1.18	0.21	-	-	-
Operating Expenses	55.34	39.27	22.62	17.66	21.87	8.82
Operating Income	-55.34	-39.27	-22.62	-17.66	-21.87	-8.82
Interest Expense	-2.58	-0.28	-0.12	-0.09	-0.04	-0
Interest & Investment Income	-	2.2	0.55	0.14	0.4	0.01
Currency Exchange Gain (Loss)	1.35	1.35	-0.05	0.35	-	-
Other Non Operating Income (Expenses)	2.95	0.91	0.61	0.06	-0.01	-0
EBT Excluding Unusual Items	-53.62	-35.09	-21.63	-17.19	-21.52	-8.83
Gain (Loss) on Sale of Investments	-	-	-	-0.25	-	-
Gain (Loss) on Sale of Assets	-0.26	-0.26	-0.02	-	-	-
Asset Writedown	-	-	-0.2	-	-	-
Other Unusual Items	-	-	-	-	-	-5.61
Pretax Income	-53.88	-35.35	-21.84	-17.44	-21.52	-14.43
Net Income	-53.88	-35.35	-21.84	-17.44	-21.52	-14.43
Net Income to Common	-53.88	-35.35	-21.84	-17.44	-21.52	-14.43
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	335	297	218	168	135	69
Shares Outstanding (Diluted)	335	297	218	168	135	69
Shares Change	35.14%	36.29%	29.65%	24.83%	95.66%	119.52%
EPS (Basic)	-0.16	-0.12	-0.10	-0.10	-0.16	-0.21
EPS (Diluted)	-0.16	-0.12	-0.10	-0.10	-0.16	-0.21
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-55.29	-39.41	-26.68	-18.57	-14.95	-4.51
Free Cash Flow Per Share	-0.17	-0.13	-0.12	-0.11	-0.11	-0.07
EBITDA	-52.64	-37.79	-22.49	-17.48	-21.84	-8.82
D&A For EBITDA	2.7	1.48	0.12	0.18	0.03	0
EBIT	-55.34	-39.27	-22.62	-17.66	-21.87	-8.82

SEC Filings: 10-K · 10-Q